How common is Lung cancer?

Ushbu sahifani tinglang

O'pka saratoni qanchalik keng tarqalgan?

O'pka saratoni butun dunyo bo'ylab eng keng tarqalgan saraton turlaridan biridir.

Jahon sog'liqni saqlash tashkiloti (JSST) ma'lumotlariga ko'ra, o'pka saratoni butun dunyo bo'ylab saratondan o'limning asosiy sababi bo'lib, 2020 yilda 1,8 million yangi holat va 1,6 million o'lim qayd etilgan.

Qo'shma Shtatlarda bu erkaklarda ham, ayollarda ham eng ko'p uchraydigan ikkinchi saraton kasalligi bo'lib, 2021 yilda 228,810 ta yangi holat qayd etilgan.

O'pka saratoni kasalligi va o'lim ko'rsatkichlari mintaqaga qarab farq qiladi, rivojlangan mamlakatlarda va erkaklar orasida yuqori ko'rsatkichlar mavjud.

Biroq, so'nggi yillarda chekish tarqalishining pasayishi tufayli o'pka saratonining ko'payishi kamayib bormoqda.

Ma'lumotlar

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chang S, Dai M, Ren JS, Chen YH, Guo LW: [Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (4): 391-4.

Nguyen RH, Vater LB, Timsina LR, Durm GA, Rupp K, Wright K, Spitznagle MH, Paul B, Jalal SI, Carter-Harris L, Hudmon KS, Hanna NH, Loehrer PJ, Ceppa DP: Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence. PLoS One. 2021, 16 (4): e0250285.

Tabatabai MA, Kengwoung-Keumo JJ, Oates GR, Guemmegne JT, Akinlawon A, Ekadi G, Fouad MN, Singh KP: Racial and Gender Disparities in Incidence of Lung and Bronchus Cancer in the United States: A Longitudinal Analysis. PLoS One. , 11 (9): e0162949.

Karim-Kos HE, Janssen-Heijnen ML, van Iersel CA, van der Meer RM, de Vries E, Coebergh JW: The beginning of the end of the lung cancer epidemic in Dutch women? Int J Cancer. 2008, 123 (6): 1472-5.

Putila JJ, Guo NL: Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS One. 2011, 6 (10): e25886.

Strand TE, Malayeri C, Eskonsipo PK, Grimsrud TK, Norstein J, Grotmol T: Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954-1998. Cancer Causes Control. 2004, 15 (1): 27-33.

Mas'uliyatdan voz kechish: tibbiy

Ushbu veb-sayt faqat ta'lim va axborot maqsadlari uchun mo'ljallangan bo'lib, tibbiy maslahat yoki professional xizmatlar ko'rsatmaydi.

Ma'lumotlardan sog'liqni saqlash muammolari yoki kasalliklarni tashxislash yoki davolash uchun foydalanmaslik kerak va shaxsiy tibbiy maslahat so'raganlar litsenziyaga ega bo'lgan shifokor bilan maslahatlashishlari kerak.

Iltimos, savollarga javoblarni ishlab chiqaradigan neyron tarmog'i, ayniqsa, raqamli tarkibga kelganda noto'g'ri ekanligiga e'tibor bering. Masalan, ma'lum bir kasallik bilan kasallangan odamlar soni.

Har doim shifokoringiz yoki boshqa malakali sog'liqni saqlash provayderining maslahatini so'rang. Hech qachon professional tibbiy maslahatni e'tiborsiz qoldirmang yoki ushbu veb-saytda o'qiganingiz sababli uni so'rashni kechiktirmang. Agar siz tibbiy favqulodda vaziyatga duchor bo'lishingiz mumkin deb o'ylasangiz, darhol 911 ga qo'ng'iroq qiling yoki eng yaqin favqulodda vaziyatlar bo'limiga boring. Ushbu veb-sayt yoki uning ishlatilishi bilan hech qanday shifokor- bemor munosabatlari yaratilmaydi. BioMedLib ham, uning xodimlari ham, ushbu veb-saytga hech qanday hissa qo'shuvchi, bu erda taqdim etilgan ma'lumot yoki uning ishlatilishi bilan bog'liq hech qanday bayonot bermaydi.

Mas'uliyatdan voz kechish: mualliflik huquqi

1998-yilgi raqamli ming yillik mualliflik huquqi to'g'risidagi qonun, 17 U.S.C. 512-moddasi (DMCA) Internetda paydo bo'lgan materiallar AQSh mualliflik huquqi to'g'risidagi qonun bo'yicha o'z huquqlarini buzadi deb hisoblaydigan mualliflik huquqi egalari uchun choralar ko'rsatadi.

Agar siz bizning veb-saytimiz yoki xizmatlarimiz bilan bog'liq bo'lgan har qanday tarkib yoki material sizning mualliflik huquqingizni buzadi deb yaxshi ishonchga ega bo'lsangiz, siz (yoki sizning vakilingiz) bizga tarkib yoki materialni olib tashlashni yoki unga kirishni to'xtatishni so'rab xabar yuborishingiz mumkin.

Xabarlar yozma ravishda elektron pochta orqali yuborilishi kerak (elektron pochta manzili uchun "Muloqot" bo'limiga qarang).

DMCA sizning da'vo qilingan mualliflik huquqi buzilganligi to'g'risidagi xabarnomangizda quyidagi ma'lumotlarni o'z ichiga olishini talab qiladi: (1) da'vo qilingan mualliflik huquqi buzilgan asarning tavsifi; (2) da'vo qilingan mualliflik huquqi buzilgan tarkibning tavsifi va bizga tarkibni topishga imkon beradigan etarli ma'lumotlar; (3) siz uchun aloqa ma'lumotlari, shu jumladan sizning manzilingiz, telefon raqami va elektron pochta manzili; (4) siz tomonidan da'vo qilingan tarzda tarkib mualliflik huquqi egasi yoki uning vakili yoki har qanday qonun tomonidan ruxsat berilmaganligiga ishonchingiz borligi to'g'risidagi bayonot;

(5) siz tomonidan yolg'on guvohlik berish jazosi ostida imzolangan, bildirishnomadagi ma'lumotlar to'g'ri ekanligi va siz buzilgan deb da'vo qilingan mualliflik huquqlarini amalga oshirish vakolatiga ega ekanligingiz to'g'risidagi bayonot;

va (6) mualliflik huquqi egasining yoki mualliflik huquqi egasi nomidan harakat qilishga vakolatli shaxsning jismoniy yoki elektron imzosi.

Yuqoridagi barcha ma'lumotlarni kiritmaslik sizning shikoyatingizni ko'rib chiqishni kechiktirishi mumkin.

Aloqa qilish

Iltimos, har qanday savol / taklif bilan bizga elektron pochta xabarini yuboring.

How common is lung cancer?

Lung cancer is one of the most common types of cancer worldwide.

According to the World Health Organization (WHO), lung cancer is the leading cause of cancer deaths globally, with an estimated 1.8 million new cases and 1.6 million deaths in 2020.

In the United States, it is the second most common cancer in both men and women, with an estimated 228,810 new cases in 2021.

The incidence and mortality rates of lung cancer vary by region, with higher rates in developed countries and among males.

However, the incidence of lung cancer has been decreasing in recent years due to decreased smoking prevalence.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.